Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Express Scripts
Johnson and Johnson
Baxter
AstraZeneca

Last Updated: May 27, 2022

Erdafitinib - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for erdafitinib and what is the scope of freedom to operate?

Erdafitinib is the generic ingredient in one branded drug marketed by Janssen Biotech and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Erdafitinib has one hundred and sixty-three patent family members in forty-one countries.

One supplier is listed for this compound.

Summary for erdafitinib
International Patents:163
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 41
Clinical Trials: 24
Patent Applications: 433
What excipients (inactive ingredients) are in erdafitinib?erdafitinib excipients list
DailyMed Link:erdafitinib at DailyMed
Recent Clinical Trials for erdafitinib

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Memorial Sloan Kettering Cancer CenterPhase 2
M.D. Anderson Cancer CenterPhase 2
University of WashingtonPhase 2

See all erdafitinib clinical trials

US Patents and Regulatory Information for erdafitinib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Biotech BALVERSA erdafitinib TABLET;ORAL 212018-003 Apr 12, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Janssen Biotech BALVERSA erdafitinib TABLET;ORAL 212018-003 Apr 12, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Janssen Biotech BALVERSA erdafitinib TABLET;ORAL 212018-002 Apr 12, 2019 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Janssen Biotech BALVERSA erdafitinib TABLET;ORAL 212018-001 Apr 12, 2019 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Janssen Biotech BALVERSA erdafitinib TABLET;ORAL 212018-003 Apr 12, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for erdafitinib

Country Patent Number Title Estimated Expiration
Australia 2017202512 PYRAZOLYL QUINOXALINE KINASE INHIBITORS See Plans and Pricing
European Patent Office 3590934 INHIBITEURS DE KINASE DE QUINOXALINE PYRAZOLYLE (PYRAZOLYL QUINOXALINE KINASE INHIBITORS) See Plans and Pricing
Israel 281024 See Plans and Pricing
Mexico 2019009304 TRATAMIENTO PARA EL CANCER. (CANCER TREATMENT.) See Plans and Pricing
South Korea 20170110145 N--N'--N-[3-(1-메틸-1H-피라졸-4-일)퀴녹살린-6-일]에탄-1,2-디아민을 포함하는 제약 조성물 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
AstraZeneca
Merck
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.